Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe

Seagen Inc. is making good progress with its portfolio of marketed drugs — Adcetris, Padcev, Tukysa and the newly approved Tivdak — targeting different types of cancer indications.